BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nagelkerke SQ, Schmidt DE, de Haas M, Kuijpers TW. Genetic Variation in Low-To-Medium-Affinity Fcγ Receptors: Functional Consequences, Disease Associations, and Opportunities for Personalized Medicine. Front Immunol 2019;10:2237. [PMID: 31632391 DOI: 10.3389/fimmu.2019.02237] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Barliana MI, Afifah NN, Amalia R, Hamijoyo L, Abdulah R. Genetic Polymorphisms and the Clinical Response to Systemic Lupus Erythematosus Treatment Towards Personalized Medicine. Front Pharmacol 2022;13:820927. [DOI: 10.3389/fphar.2022.820927] [Reference Citation Analysis]
2 Junker F, Gordon J, Qureshi O. Fc Gamma Receptors and Their Role in Antigen Uptake, Presentation, and T Cell Activation. Front Immunol 2020;11:1393. [PMID: 32719679 DOI: 10.3389/fimmu.2020.01393] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
3 Warrender AK, Kelton W. Beyond Allotypes: The Influence of Allelic Diversity in Antibody Constant Domains. Front Immunol 2020;11:2016. [PMID: 32973808 DOI: 10.3389/fimmu.2020.02016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Papaserafeim M, Jandus P, Iancu Ferfoglia R, Nieke JP, Vonarburg C, Spirig R, Puga Yung GL, Seebach JD. Effect of intravenous IgG therapy on natural killer cell function related to Fc gamma receptor gene expression. J Allergy Clin Immunol 2020;146:667-70. [PMID: 32311389 DOI: 10.1016/j.jaci.2020.04.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
5 Murin CD. Considerations of Antibody Geometric Constraints on NK Cell Antibody Dependent Cellular Cytotoxicity. Front Immunol 2020;11:1635. [PMID: 32849559 DOI: 10.3389/fimmu.2020.01635] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
6 Aitken EH, Mahanty S, Rogerson SJ. Antibody effector functions in malaria and other parasitic diseases: a few needles and many haystacks. Immunol Cell Biol 2020;98:264-75. [DOI: 10.1111/imcb.12320] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
7 Wang Z, Zhou H, Yue X, Zhu J, Yang Y, Liu M. An auxiliary binding interface of SHIP2-SH2 for Y292-phosphorylated FcγRIIB reveals diverse recognition mechanisms for tyrosine-phosphorylated receptors involved in different cell signaling pathways. Anal Bioanal Chem 2021. [PMID: 34021368 DOI: 10.1007/s00216-021-03373-w] [Reference Citation Analysis]
8 Moraru M, Perez-Portilla A, Al-Akioui Sanz K, Blazquez-Moreno A, Arnaiz-Villena A, Reyburn HT, Vilches C. FCGR Genetic Variation in Two Populations From Ecuador Highlands-Extensive Copy-Number Variation, Distinctive Distribution of Functional Polymorphisms, and a Novel, Locally Common, Chimeric FCGR3B/A (CD16B/A) Gene. Front Immunol 2021;12:615645. [PMID: 34108956 DOI: 10.3389/fimmu.2021.615645] [Reference Citation Analysis]
9 Bugaj B, Wielińska J, Bogunia-kubik K, Świerkot J. Searching for New Genetic Biomarkers of Axial Spondyloarthritis. JCM 2022;11:2912. [DOI: 10.3390/jcm11102912] [Reference Citation Analysis]
10 Bishnoi A, De D, Handa S, Mahajan R. Biologics in autoimmune bullous diseases: Current scenario. Indian J Dermatol Venereol Leprol 2021;87:611-20. [PMID: 34245525 DOI: 10.25259/IJDVL_886_19] [Reference Citation Analysis]
11 Pollara J, Tay MZ, Edwards RW, Goodman D, Crowley AR, Edwards RJ, Easterhoff D, Conley HE, Hoxie T, Gurley T, Jones C, Machiele E, Tuyishime M, Donahue E, Jha S, Spreng RL, Hope TJ, Wiehe K, He MM, Moody MA, Saunders KO, Ackerman ME, Ferrari G, Tomaras GD. Functional Homology for Antibody-Dependent Phagocytosis Across Humans and Rhesus Macaques. Front Immunol 2021;12:678511. [PMID: 34093580 DOI: 10.3389/fimmu.2021.678511] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Kassem S, Diallo BK, El-Murr N, Carrié N, Tang A, Fournier A, Bonnevaux H, Nicolazzi C, Cuisinier M, Arnould I, Sidhu SS, Corre J, Avet-Loiseau H, Teillaud JL, van de Velde H, Wiederschain D, Chiron M, Martinet L, Virone-Oddos A. SAR442085, a novel anti-CD38 antibody with enhanced antitumor activity against multiple myeloma. Blood 2022;139:1160-76. [PMID: 35201323 DOI: 10.1182/blood.2021012448] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Pérez-Rubio G, Ponce-Gallegos MA, Domínguez-Mazzocco BA, Ponce-Gallegos J, García-Ramírez RA, Falfán-Valencia R. Role of the Host Genetic Susceptibility to 2009 Pandemic Influenza A H1N1. Viruses 2021;13:344. [PMID: 33671828 DOI: 10.3390/v13020344] [Reference Citation Analysis]
14 Alcaide EG, Krishnarajah S, Junker F. Dendritic Cell Tumor Vaccination via Fc Gamma Receptor Targeting: Lessons Learned from Pre-Clinical and Translational Studies. Vaccines (Basel) 2021;9:409. [PMID: 33924183 DOI: 10.3390/vaccines9040409] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Webb NE, Bernshtein B, Alter G. Tissues: the unexplored frontier of antibody mediated immunity. Curr Opin Virol 2021;47:52-67. [PMID: 33581646 DOI: 10.1016/j.coviro.2021.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Guo J, Han B, Wang J, Zhang L, Chen N, Sun W, Gao Y. The differential expression and potential roles of circular RNAs in children with anti-NMDA receptor encephalitis. J Neuroimmunol 2020;348:577381. [PMID: 32911360 DOI: 10.1016/j.jneuroim.2020.577381] [Reference Citation Analysis]
17 Sundström Y, Shang MM, Panda SK, Grönwall C, Wermeling F, Gunnarsson I, Lundberg IE, Sundström M, Jakobsson PJ, Berg L. Identifying novel B-cell targets for chronic inflammatory autoimmune disease by screening of chemical probes in a patient-derived cell assay. Transl Res 2021;229:69-82. [PMID: 32977027 DOI: 10.1016/j.trsl.2020.09.003] [Reference Citation Analysis]
18 Minguela A, Salido EJ, Soto-Ramírez MF, Olga MA, Leal JD, García-Garay MC, Periago A, Berenguer M, Blanque M, Campillo JA. Low-affinity immunoglobulin gamma Fc region receptor III-B (FcγRIIIB, CD16B) deficiency in patients with blood and immune system disorders. Br J Haematol 2021;195:743-7. [PMID: 34544201 DOI: 10.1111/bjh.17828] [Reference Citation Analysis]
19 Wu L, Xu Y, Zhao H, Zhou Y, Chen Y, Yang S, Lei J, Zhang J, Wang J, Wu Y, Li Y. FcγRIIB potentiates differentiation of myeloid-derived suppressor cells to mediate tumor immunoescape. Theranostics 2022;12:842-58. [PMID: 34976216 DOI: 10.7150/thno.66575] [Reference Citation Analysis]
20 Nagelkerke SQ, Porcelijn L, Geissler J, Tanck MWT, Huiskes E, van Bruggen R, van den Berg TK, de Haas M, Kuijpers TW. The association and functional relevance of genetic variation in low-to-medium-affinity Fc-gamma receptors with clinical platelet transfusion refractoriness. J Thromb Haemost 2020;18:2047-53. [PMID: 32588549 DOI: 10.1111/jth.14892] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Pietzner M, Wheeler E, Carrasco-Zanini J, Kerrison ND, Oerton E, Koprulu M, Luan J, Hingorani AD, Williams SA, Wareham NJ, Langenberg C. Synergistic insights into human health from aptamer- and antibody-based proteomic profiling. Nat Commun 2021;12:6822. [PMID: 34819519 DOI: 10.1038/s41467-021-27164-0] [Reference Citation Analysis]
22 van Faassen H, Jo DH, Ryan S, Lowden MJ, Raphael S, MacKenzie CR, Lee SH, Hussack G, Henry KA. Incorporation of a Novel CD16-Specific Single-Domain Antibody into Multispecific Natural Killer Cell Engagers With Potent ADCC. Mol Pharm 2021;18:2375-84. [PMID: 33999642 DOI: 10.1021/acs.molpharmaceut.1c00208] [Reference Citation Analysis]
23 Gatault P, Lajoie L, Stojanova J, Halimi JM, Caillard S, Moyrand S, Martinez D, Ladrière M, Morelon E, Merville P, Essig M, Vigneau C, Kamar N, Bouvier N, Westeel PF, Mariat C, Hazzan M, Thierry A, Etienne I, Büchler M, Marquet P, Gouilleux-Gruart V, Thibault G. The FcγRIIIA-158 VV genotype increased the risk of post-transplant lymphoproliferative disorder in T-cell-depleted kidney transplant recipients - a retrospective study. Transpl Int 2020;33:936-47. [PMID: 32314433 DOI: 10.1111/tri.13624] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Capuano C, Pighi C, Battella S, De Federicis D, Galandrini R, Palmieri G. Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbs. Cancers (Basel) 2021;13:2500. [PMID: 34065399 DOI: 10.3390/cancers13102500] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Gornowicz-Porowska J, Kowalczyk MJ, Seraszek-Jaros A, Bowszyc-Dmochowska M, Kaczmarek E, Żaba R, Dmochowski M. A Comparative Analysis of CD32A and CD16A Polymorphisms in Relation to Autoimmune Responses in Pemphigus Diseases and Subepithelial Autoimmune Blistering Disorders. Genes (Basel) 2020;11:E371. [PMID: 32235430 DOI: 10.3390/genes11040371] [Reference Citation Analysis]
26 Amiah MA, Ouattara A, Okou DT, N'Guetta SA, Yavo W. Polymorphisms in Fc Gamma Receptors and Susceptibility to Malaria in an Endemic Population. Front Immunol 2020;11:561142. [PMID: 33281811 DOI: 10.3389/fimmu.2020.561142] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]